{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:33:00Z","timestamp":1767677580603,"version":"3.48.0"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: The diagnostic and therapeutic landscape of amyloidosis has evolved significantly with the introduction of non-invasive imaging and novel agents. However, contemporary real-world data reflecting these recent changes\u2014particularly regarding the burden and prognostic impact of cardiac involvement\u2014remain limited. We aimed to evaluate up-to-date temporal trends in the incidence, prevalence, and outcomes of amyloidosis using a nationwide cohort spanning the recent era. Methods: Using the Korean National Health Insurance Service database, we identified 5165 patients with newly diagnosed amyloidosis. Cardiac amyloidosis was defined by the presence of heart failure, cardiomyopathy, atrial fibrillation, or pacemaker implantation. Propensity score matching was performed to compare mortality risks between patients with and without cardiac involvement. Temporal trends in outcomes were analyzed across three periods (2009\u20132013, 2014\u20132018, and 2019\u20132022). Results: The incidence and prevalence of amyloidosis steadily increased, with a marked rise observed after 2019. Cardiac involvement was identified in 44.6% of patients and was associated with significantly higher risks of all-cause death (hazard ratio [HR] 1.396; 95% CI 1.214\u20131.606) and cardiovascular death (HR 1.879; 95% CI 1.254\u20132.816) in the matched cohort. Notably, while all-cause mortality gradually declined over the study period, cardiovascular mortality showed no significant improvement, remaining persistently high even in the most recent cohort. Conclusions: In this contemporary nationwide cohort, the burden of amyloidosis has grown over the past decade. Despite improvements in overall survival, the persistent risk of cardiovascular mortality highlights a critical unmet need for targeted cardiovascular management in this population.<\/jats:p>","DOI":"10.3390\/jcm15010313","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:08:00Z","timestamp":1767197280000},"page":"313","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal Trends and Outcomes of Amyloidosis in Korea: A 14-Year Nationwide Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0224-5178","authenticated-orcid":false,"given":"Mi-Hyang","family":"Jung","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5102-9212","authenticated-orcid":false,"given":"Hae Ok","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8525-9547","authenticated-orcid":false,"given":"So-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-503X","authenticated-orcid":false,"given":"Jong-Chan","family":"Youn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo Reum","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-8024","authenticated-orcid":false,"given":"Hoseob","family":"Kim","sequence":"additional","affiliation":[{"name":"Data Science Team, Hanmi Pharm. Co., Ltd., Seoul 05545, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-2957","authenticated-orcid":false,"given":"Woo-Baek","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jung, M.H., Chang, S., Han, E.J., and Youn, J.C. (2022). Multimodal Imaging and Biomarkers in Cardiac Amyloidosis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030627"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaccao.2021.05.004","article-title":"Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study","volume":"3","author":"Westin","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"oead106","DOI":"10.1093\/ehjopen\/oead106","article-title":"Cardiac amyloidosis and aortic stenosis: A state-of-the-art review","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur. Heart J. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e009038","DOI":"10.1161\/CIRCHEARTFAILURE.121.009038","article-title":"Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report from the Amyloidosis Forum Cardiac Working Group","volume":"15","author":"Maurer","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4070\/kcj.2013.43.11.752","article-title":"Incidence, diagnosis and prognosis of cardiac amyloidosis","volume":"43","author":"Lee","year":"2013","journal-title":"Korean Circ. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.3346\/jkms.2025.40.e111","article-title":"Leveraging National Health Insurance Service Data for Public Health Research in Korea: Structure, Applications, and Future Directions","volume":"40","author":"Lim","year":"2025","journal-title":"J. Korean Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ehjqcco\/qcae055","article-title":"Socioeconomic status and cardiovascular mortality in over 170 000 cancer survivors","volume":"11","author":"Jung","year":"2025","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/eurjpc\/zwae345","article-title":"Sodium-glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: A population-based cohort study","volume":"32","author":"Jung","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.36628\/ijhf.2021.0026","article-title":"Using Big Data to Understand Rare Diseases","volume":"3","author":"Park","year":"2021","journal-title":"Int. J. Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.3346\/jkms.2024.39.e163","article-title":"Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study","volume":"39","author":"Kim","year":"2024","journal-title":"J. Korean Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: A real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2021.04.023","article-title":"Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany","volume":"335","author":"Zampieri","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: Cracking the glass ceiling of early death","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13506129.2025.2463678","article-title":"Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines","volume":"32","author":"Muchtar","year":"2025","journal-title":"Amyloid"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5045\/br.2022.2021227","article-title":"Multidisciplinary supportive care in systemic light chain amyloidosis","volume":"57","author":"Maroun","year":"2022","journal-title":"Blood Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s12185-022-03525-3","article-title":"A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea","volume":"117","author":"Yoon","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.36628\/ijhf.2023.0011","article-title":"Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment","volume":"5","author":"Youn","year":"2023","journal-title":"Int. J. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Park, S.S., Choi, S., Jung, S., Han, S., Lee, C., Han, J., Kim, S., Kim, K., and Min, C.K. (2025). Cost-Effectiveness Analysis of Daratumumab Monotherapy and Subsequent Therapies in Heavily Treated Relapsed\/Refractory Multiple Myeloma: A Feasible Methodology using a Korean Nationwide Population Cohort. Cancer Res. Treat., Epub ahead of print.","DOI":"10.4143\/crt.2025.046"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/RLU.0000000000005784","article-title":"Concomitant ATTR and AL Cardiac Amyloidosis with Matching 99m Tc-DPD Scintigraphy and 18 F-Flutemetamol PET\/CT","volume":"50","author":"Youn","year":"2025","journal-title":"Clin. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Jung, M.H., Jung, M.K., Kim, E.S., Youn, J.C., Lee, E.Y., Kang, D., Kyoung, D.S., Chung, W.B., Jung, H.O., and Ihm, S.H. (2025). Adherence to Antidiabetic Medication and Cardiovascular Outcomes in Cancer Patients: A Nationwide Population-Based Cohort Study. Cancers, 17.","DOI":"10.3390\/cancers17071117"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/ehf2.14803","article-title":"Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer","volume":"11","author":"Lee","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4070\/kcj.2024.0334","article-title":"CMR Parametric Mapping Helps Diagnose Diffuse Myocardial Leukemic Infiltration in the Relapse of Acute Lymphoblastic Leukemia","volume":"55","author":"Beck","year":"2025","journal-title":"Korean Circ. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e029362","DOI":"10.1161\/JAHA.123.029362","article-title":"Antihypertensive Medication Adherence and Cardiovascular Outcomes in Patients with Cancer: A Nationwide Population-Based Cohort Study","volume":"12","author":"Jung","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/eurjpc\/zwac241","article-title":"Cardiovascular health is the essential but overlooked aspect in the management of cancer survivors","volume":"29","author":"Ahn","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Matteucci, A., Pandozi, C., Bonanni, M., Mariani, M.V., Sgarra, L., Nesti, L., Pierucci, N., La Fazia, V.M., Lavalle, C., and Nardi, F. (2025). Impact of empagliflozin and dapagliflozin on sudden cardiac death: A systematic review and meta-analysis of adjudicated randomized evidence. Heart Rhythm., Epub ahead of print.","DOI":"10.1016\/j.hrthm.2025.09.023"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"D278","DOI":"10.1093\/eurheartjsupp\/suad106","article-title":"ANMCO position paper on vericiguat use in heart failure: From evidence to place in therapy","volume":"25","author":"Alonzo","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for Hereditary Transthyretin Amyloidosis with Polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2022019406","article-title":"Birtamimab plus standard of care in light-chain amyloidosis: The phase 3 randomized placebo-controlled VITAL trial","volume":"142","author":"Gertz","year":"2023","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Foster, J.S., Balachandran, M., Hancock, T.J., Martin, E.B., Macy, S., Wooliver, C., Richey, T., Stuckey, A., Williams, A.D., and Jackson, J.W. (2023). Development and characterization of a prototypic pan-amyloid clearing agent\u2014A novel murine peptide-immunoglobulin fusion. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1275372"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/313\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:27:27Z","timestamp":1767677247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010313"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010313","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}